MEDICUS PHARMA LTD. Shares Authorized
MEDICUS PHARMA LTD. (MDCX) had Shares Authorized of 60.17 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-12
- 2026-06-30: Common Stock, Shares Authorized 60.17M shares.
- 2026-03-31: Common Stock, Shares Authorized 40.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 25.18M shares.
- 2024-12-31: Common Stock, Shares Authorized 11.82M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 60.17M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 40.00M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 25.18M shares 10-Q · filed 2026-08-12 |
| 2024-12-31 | 11.82M shares 10-K · filed 2026-03-25 |
| 2023-12-31 | 8.08M shares 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |